Mesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future Potential

Area of Science:

• Regenerative Medicine
• Biomedical Engineering
• Dermatology

Background:

• Human skin possesses remarkable self-repair capabilities crucial for survival.
• Chronic wounds are an increasing biomedical burden due to aging populations and conditions like diabetes.
• Mesenchymal stem cells (MSC) are key mediators in inflammatory processes relevant to healing.

Purpose of the Study:

• To review evidence on MSC's efficacy in accelerating wound healing.
• To explore the mechanisms underlying MSC's therapeutic effects.
• To discuss challenges in translating MSC into a medicinal product.

Main Methods:

• Systematic review of preclinical (animal models) and clinical studies.
• Analysis of proposed mechanisms of action for MSC in wound repair.
• Examination of safety, ethical, and regulatory considerations for MSC therapy.

Main Results:

• Preclinical and clinical data suggest MSC significantly accelerate wound healing.
• MSC modulate inflammatory environments, promoting tissue regeneration.
• Evidence points to specific mechanisms by which MSC enhance healing efficacy.

Conclusions:

• Mesenchymal stem cells represent a promising therapeutic strategy for accelerating wound healing.
• Understanding MSC mechanisms is crucial for optimizing their clinical application.
• Addressing safety, ethical, and regulatory hurdles is essential for widespread MSC therapy adoption.